Chemours Company (The) (NYSE: CC) stock closed at 30.12 per share at the end of the most recent trading day (a -1.02% change compared to the prior day closing price) with a volume of 556.62K shares and market capitalization of 4.46B. Is a component of Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Chemicals industry, Basic Materials sector and employs 6500 people. Chemours Company (The) CEO is Mark P. Vergnano.

The one-year performance of Chemours Company (The) stock is 14.18%, while year-to-date (YTD) performance is -1.63%. CC stock has a five-year performance of -26.61%. Its 52-week range is between 23.58 and 39.05, which gives CC stock a 52-week price range ratio of 42.28%

Chemours Company (The) currently has a PE ratio of 5.80, a price-to-book (PB) ratio of 3.81, a price-to-sale (PS) ratio of 0.90, a price to cashflow ratio of 6.50, a PEG ratio of 0.76, a ROA of 12.86%, a ROC of 20.59% and a ROE of 85.28%. The company’s profit margin is 12.37%, its EBITDA margin is 22.30%, and its revenue ttm is $5.46 Billion , which makes it $36.15 revenue per share.

Of the last four earnings reports from Chemours Company (The), there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $0.83 for the next earnings report. Chemours Company (The)’s next earnings report date is 24th Oct 2023.

The consensus rating of Wall Street analysts for Chemours Company (The) is Hold (2.64), with a target price of $33.8, which is +12.22% compared to the current price. The earnings rating for Chemours Company (The) stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Chemours Company (The) has a dividend yield of 3.07% with a dividend per share of $1.00 and a payout ratio of 78.00%.

Chemours Company (The) has a Sell technical analysis rating based on Technical Indicators (ADX : 11.38, ATR14 : 0.84, CCI20 : -136.03, Chaikin Money Flow : -0.24, MACD : -0.97, Money Flow Index : 10.62, ROC : -9.58, RSI : 29.87, STOCH (14,3) : 0.45, STOCH RSI : 0.00, UO : 27.32, Williams %R : -99.55), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Chemours Company (The) in the last 12-months were: Alisha Bellezza (Option Excercise at a value of $658 266), Alisha Bellezza (Sold 27 716 shares of value $983 087 ), Bellezza Alisha (Option Excercise at a value of $658 266), Bellezza Alisha (Sold 27 716 shares of value $983 087 ), Mark E. Newman (Buy at a value of $249 978), Matthew S. Abbott (Option Excercise at a value of $128 600), Matthew S. Abbott (Sold 8 912 shares of value $304 790 ), Scarborough Alvenia (Option Excercise at a value of $73 954), Scarborough Alvenia (Sold 5 125 shares of value $165 538 )